What is the current Price Target for the Reviva Pharmaceuticals Holdings Inc. stock?

The average Reviva Pharmaceuticals Holdings Inc. target price is $30.60. This is 5,994.40% higher than the current stock price. The highest price target is 16,629.74%, the lowest is 1,308.09%. 7 Analysts have issued a price target Reviva Pharmaceuticals Holdings Inc. 2027 .

How high will the Reviva Pharmaceuticals Holdings Inc. stock rise?

No reliable answer can be given as to how high the Reviva Pharmaceuticals Holdings Inc. stock will rise. The performance of stocks, including the Reviva Pharmaceuticals Holdings Inc. stock, depends on a variety of factors, such as the general economic situation, the company's business results, investor expectations and global events.

What's going on with the Reviva Pharmaceuticals Holdings Inc. stock today?

The performance of Reviva Pharmaceuticals Holdings Inc. stock on any given day can be influenced by various factors, such as market conditions, industry trends, company news and global events.

Why did the Reviva Pharmaceuticals Holdings Inc. stock fall?

The decline in Reviva Pharmaceuticals Holdings Inc. stock may be due to a variety of factors, such as market conditions, industry trends, company news, macroeconomic events or changes in investor expectations. It is important to note that stock markets are inherently volatile and the performance of an individual stock on any given day is not necessarily indicative of its long-term performance.

What is a price target?

A price target is an estimate by an analyst or investment bank of where a company's stock price could be in a certain period of time, usually 12 months.

Reviva Pharmaceuticals Holdings Inc. Forecast, price target & analysts

$0.49

0.00%

Nasdaq, Sep 17, 02:34 pm EDT. Closed.

ISIN

US76152G1004

Symbol

RVPH

Reports

Quarter | Annual

Index

NASDAQ Composite

Sector

Pharmaceuticals, Biotechnology & Life Sciences

Industry

Pharmaceuticals

Overview Analysts Charts Ownership News Strategies

Reviva Pharmaceuticals Holdings Inc. Target price 2026 - Analyst rating & recommendation

Reviva Pharmaceuticals Holdings Inc. Classifications & Recommendation

Buy

82%

Hold

18%

Reviva Pharmaceuticals Holdings Inc. Price Target

Target Price	$30.60
Price	$0.50
Potential	5,994.40% register free of charge
Number of Estimates	7

	7 Analysts have issued a price target Reviva Pharmaceuticals Holdings Inc. 2027 . The average Reviva Pharmaceuticals Holdings Inc. target price is $30.60. This is 5,994.40% register free of charge higher than the current stock price. The highest price target is $84.00 16,629.74% register free of charge , the lowest is $7.07 1,308.09% register free of charge .
	A rating was issued by 11 analysts: 9 Analysts recommend Reviva Pharmaceuticals Holdings Inc. to buy, 2 to hold and 0 to sell.
	Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis.
	Analyst Estimates: Analysts believe that the Reviva Pharmaceuticals Holdings Inc. stock has an average upside potential 2027 of 5,994.40% register free of charge . Most analysts recommend the Reviva Pharmaceuticals Holdings Inc. stock at Purchase.

Earnings per share, P/E ratio and EV/sales Estimates 2026, 2027 to 2032

Create a premium account to unlock analyst estimates. Learn more

Annually

	Dec '25	2026 Estimates
Earnings Per Share $	-5.48	-2.54
	69.64%	53.65%
P/E		negative

8 Analysts have issued a Reviva Pharmaceuticals Holdings Inc. forecast for earnings per share. The average Reviva Pharmaceuticals Holdings Inc. EPS is

unlock

. This is

unlock

than earnings per share in the financial year 2025. The highest EPS forecast is

unlock

, the lowest is

unlock

This results in the following potential growth metrics and future valuations:

2025	$-5.48	69.64%
2026	$-2.54 53.65% unlock
2027	$-1.18 53.54% unlock
2028	$-1.03 12.71% unlock
2029	$-0.43 58.25% unlock
2030	$0.16 137.21% unlock
2031	$0.66 312.50% unlock
2032	$1.09 65.15% unlock

Current	-0.15	81.65%
2026	-0.20 33.07% unlock
2027	-0.42 110.00% unlock
2028	-0.49 16.67% unlock
2029	-0.96 95.92% unlock
2030	2.51 361.46% unlock
2031	0.62 75.30% unlock

Reviva Pharmaceuticals Holdings Inc....

Current Reviva Pharmaceuticals Holdings Inc. Upgrades & Downgrades

Create a Premium account to unlock Upgrades/Downgrades. Learn more

Analyst	Rating	Action	Date
Maxim Group	Locked ➜ Locked	Locked	Apr 08 2026
D. Boral Capital	Locked ➜ Locked	Locked	Mar 05 2026
Chardan Capital	Locked ➜ Locked	Locked	Jan 05 2026
HC Wainwright & Co.	Locked ➜ Locked	Locked	Dec 23 2025
D. Boral Capital	Locked ➜ Locked	Locked	Dec 23 2025
D. Boral Capital	Locked ➜ Locked	Locked	Nov 19 2025
D. Boral Capital	Locked ➜ Locked	Locked	Oct 28 2025

Analyst Rating	Date
Locked Maxim Group: Locked ➜ Locked	Apr 08 2026
Locked D. Boral Capital: Locked ➜ Locked	Mar 05 2026
Locked Chardan Capital: Locked ➜ Locked	Jan 05 2026
Locked HC Wainwright & Co.: Locked ➜ Locked	Dec 23 2025
Locked D. Boral Capital: Locked ➜ Locked	Dec 23 2025
Locked D. Boral Capital: Locked ➜ Locked	Nov 19 2025
Locked D. Boral Capital: Locked ➜ Locked	Oct 28 2025

Discover more stocks with a high price target

NIO ADR 102.31%

Alibaba Group Holding Ltd 75.49%

Infineon 69.69%

Rheinmetall 60.60%

Tencent Holdings Ltd. 60.42%

TUI 52.29%

Siemens Energy 47.46%

Adyen 47.42%

Adidas 46.48%

Uber Technologies 45.36%

BYD 41.55%

NVIDIA 39.51%

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

Start now